Inventiva S.A reports 9M results
IVA Stock | USD 2.68 0.04 1.52% |
About 55% of Inventiva's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Inventiva Sa suggests that some traders are interested. The current market sentiment, together with Inventiva's historical and current headlines, can help investors time the market. In addition, many technical investors use Inventiva Sa stock news signals to limit their universe of possible portfolio assets.
Inventiva |
Inventiva S.A reports 1.3B revenue in Q3 2024, with cash and equivalents at 13.9 million. RD expenses down 10 percent from 2023.
Read at seekingalpha.com
Inventiva Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Inventiva can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Inventiva Fundamental Analysis
We analyze Inventiva's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inventiva using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inventiva based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Inventiva is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Inventiva Sa Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inventiva stock to make a market-neutral strategy. Peer analysis of Inventiva could also be used in its relative valuation, which is a method of valuing Inventiva by comparing valuation metrics with similar companies.
Peers
Inventiva Related Equities
VRCA | Verrica Pharmaceuticals | 11.71 | ||||
GLUE | Monte Rosa | 5.93 | ||||
MLYS | Mineralys Therapeutics, | 4.71 | ||||
VIGL | Vigil Neuroscience | 4.55 | ||||
VTYX | Ventyx Biosciences | 4.33 | ||||
RZLT | Rezolute | 4.18 | ||||
IPHA | Innate Pharma | 3.45 | ||||
CMPX | Compass Therapeutics | 3.31 | ||||
PCVX | Vaxcyte | 2.77 | ||||
CGEM | Cullinan Oncology | 2.51 | ||||
ANEB | Anebulo Pharmaceuticals | 2.14 | ||||
IMCR | Immunocore Holdings | 1.17 | ||||
NAMS | NewAmsterdam Pharma | 0.19 | ||||
EWTX | Edgewise Therapeutics | 0.37 | ||||
INBX | Inhibrx | 1.15 | ||||
ELYM | Eliem Therapeutics | 1.30 | ||||
ACLX | Arcellx | 2.08 | ||||
JANX | Janux Therapeutics | 3.35 | ||||
HCWB | HCW Biologics | 10.71 |
Complementary Tools for Inventiva Stock analysis
When running Inventiva's price analysis, check to measure Inventiva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inventiva is operating at the current time. Most of Inventiva's value examination focuses on studying past and present price action to predict the probability of Inventiva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inventiva's price. Additionally, you may evaluate how the addition of Inventiva to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |